Bank of America Boosts Teladoc Health (NYSE:TDOC) Price Target to $11.50

Teladoc Health (NYSE:TDOC) had its price objective upped by research analysts at Bank of America from $10.50 to $11.50 in a report released on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the health services provider’s stock. Bank of America‘s target price suggests a potential upside of 4.59% from the company’s current price.

TDOC has been the subject of a number of other reports. Barclays increased their price target on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. The Goldman Sachs Group assumed coverage on shares of Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective for the company. Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $11.97.

Teladoc Health Price Performance

TDOC stock opened at $11.00 on Thursday. The company has a market capitalization of $1.89 billion, a P/E ratio of -1.91 and a beta of 1.04. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $21.74. The business has a 50-day simple moving average of $10.01 and a two-hundred day simple moving average of $9.09. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.95% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc increased its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC purchased a new position in Teladoc Health during the 4th quarter worth $29,000. Blue Trust Inc. increased its position in Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after buying an additional 1,854 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Teladoc Health by 162.7% during the third quarter. Signaturefd LLC now owns 7,535 shares of the health services provider’s stock valued at $69,000 after acquiring an additional 4,667 shares in the last quarter. Finally, KBC Group NV raised its position in shares of Teladoc Health by 72.3% in the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after purchasing an additional 3,714 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.